Juzen Chemical Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Japan
- Registered address
- 1-10 Kiba-machi, Toyama-city, Toyama 930-0806, Japan (JPN)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3000225055 · DUNS 691036974
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-08-01
- NAIDrug Quality Assurance2019-11-07
- VAIDrug Quality Assurance2018-03-09
- VAIDrug Quality Assurance2016-03-04
- NAIDrug Quality Assurance2012-11-01
- NAIDrug Quality Assurance2009-07-07
Drugs this plant is listed as making
3 distinct drugs across 6 products name this site in their FDA label.
- fezolinetantAstellas Pharma US, Inc.
- PegcetacoplanApellis Pharmaceuticals, Inc.
- pioglitazone and metformin hydrochlorideTakeda Pharmaceuticals America, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.